Continuous Versus Intermittent Ward Monitoring
NCT: NCT06232876 · NOT_YET_RECRUITING
Brief Summary
The investigators will randomize adults having major non-cardiac inpatient surgery to blinded versus unblinded continuous postoperative vital sign monitoring (saturation, ventilation, and heart rate). The investigators will use a wearable, untethered, and battery-powered sensor (Masimo Radius PPG, Masimo, Irvine, CA) that wirelessly connects to a Masimo monitor and continuously records saturation, ventilation, and pulse rate. The primary outcome will be areas-exceeding-thresholds for desaturation (\<85%), bradypnea (\<7 breaths/min), tachypnea (\>30 breaths/min), tachycardia (heart rate \>130 beats/min), and bradycardia (heart rate \<45 beats/min). These exposure thresholds represent a balance between events that are clinically meaningful and excessive alarms that will discourage clinician participation. The investigators expect about 1 alert per patient per day with these thresholds, with most being considered informative or actionable by nurses. In unblinded patients, clinician alerts will be activated at these thresholds.
Frequently Asked Questions
What is Continuous Versus Intermittent Ward Monitoring?
Continuous Versus Intermittent Ward Monitoring is a clinical trial registered under NCT06232876. Current status: NOT_YET_RECRUITING.
What is the status of NCT06232876?
The current status of NCT06232876 (Continuous Versus Intermittent Ward Monitoring) is: NOT_YET_RECRUITING.
When did Continuous Versus Intermittent Ward Monitoring start?
Continuous Versus Intermittent Ward Monitoring started on 2026-06-01.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.